about
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates includ...
Read More
17.36
0.53
(3.15%)
282.5K
XNAS Volume
XNAS 21 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Mesoblast Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..